Monopar Therapeutics Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
20 Jun 24 | Buy€23,866 | Andrew Cittadine | Individual | 32,508 | €0.80 | |
17 Jun 24 | Buy€30,677 | Andrew Cittadine | Individual | 36,000 | €0.87 | |
04 Jun 24 | Buy€16,983 | Andrew Cittadine | Individual | 24,000 | €0.72 | |
31 May 24 | Buy€21,255 | Andrew Cittadine | Individual | 36,000 | €0.59 |
Insider Trading Volume
Insider Buying: 1IY insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Institutions | 409,178 | 2.32% |
Individual Insiders | 2,046,819 | 11.6% |
Private Companies | 7,333,334 | 41.7% |
General Public | 7,812,496 | 44.4% |
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 24.3%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
7,333,334 | €3.2m | 0% | no data | |||
692,800 | €298.7k | 0% | no data | |||
468,750 | €202.1k | 0% | no data | |||
265,923 | €114.7k | 60.1% | no data | |||
235,863 | €101.7k | 0% | no data | |||
193,065 | €83.3k | 235% | no data | |||
192,381 | €83.0k | 556% | no data | |||
75,263 | €32.5k | 0% | no data | |||
60,036 | €25.9k | 45.7% | no data | |||
57,429 | €24.8k | 13.8% | no data | |||
45,167 | €19.5k | 0% | no data | |||
32,113 | €13.8k | 0% | no data | |||
30,863 | €13.3k | 0% | no data | |||
28,005 | €12.1k | 0% | 0.01% | |||
26,863 | €11.6k | 0% | no data | |||
18,840 | €8.1k | -20.9% | no data | |||
10,695 | €4.6k | 0% | no data | |||
7,856 | €3.4k | 117% | no data | |||
5,500 | €2.4k | 0% | no data | |||
3,000 | €1.3k | 0% | no data | |||
2,568 | €1.1k | -78.4% | no data | |||
1,500 | €646.7 | 0% | no data | |||
800 | €344.6 | 0% | no data | |||
500 | €215.6 | 0% | no data | |||
100 | €43.3 | 0% | no data |